Authors: Rodgers, GP Saunthararajah, Y

Citation: Gp. Rodgers et Y. Saunthararajah, Advances in experimental treatment of beta-thalassaemia, EXPERT OP I, 10(5), 2001, pp. 925-934

Authors: Epperson, DE Nakamura, R Saunthararajah, Y Melenhorst, J Barrett, AJ

Citation: De. Epperson et al., Oligoclonal T cell expansion in myelodysplastic syndrome: evidence for an autoimmune process, LEUK RES, 25(12), 2001, pp. 1075-1083

Authors: Saunthararajah, Y Molldrem, JJ Rivera, M Williams, A Stetler-Stevenson, M Sorbara, L Young, NS Barrett, JA

Citation: Y. Saunthararajah et al., Coincident myelodysplastic syndrome and T-cell large granular lymphocytic disease: clinical and pathophysiological features, BR J HAEM, 112(1), 2001, pp. 195-200

Authors: Maciejewski, JP Follmann, D Nakamura, R Saunthararajah, Y Rivera, CE Simonis, T Brown, KE Barrett, JA Young, NS

Citation: Jp. Maciejewski et al., Increased frequency of HLA-DR2 in patients with paroxysmal nocturnal hemoglobinuria and the PNH/aplastic anemia syndrome, BLOOD, 98(13), 2001, pp. 3513-3519

Authors: Barrett, J Saunthararajah, Y Molldrem, J

Citation: J. Barrett et al., Myelodysplastic syndrome and aplastic anemia: Distinct entities or diseases linked by a common pathophysiology?, SEM HEMATOL, 37(1), 2000, pp. 15-29

Authors: Wang, JX Saunthararajah, Y Redner, RL Liu, JM

Citation: Jx. Wang et al., Inhibitors of histone deacetylase relieve ETO-mediated repression and induce differentiation of AML1-ETO leukemia cells, CANCER RES, 59(12), 1999, pp. 2766-2769